In the last 12 months, insiders at Allarity Therapeutics, Inc. ($ALLR) filed 19 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Allarity Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Graff Jeremy R. (See Remarks) — 6 transactions totaling $273,088
- McLaughlin Gerald W. (Director) — 3 transactions totaling $0
- Epshinsky Alexander (CFO) — 1 transaction totaling $0
- Hoeiland Jesper (Director) — 1 transaction totaling $0
- Benjamin Laura (Director) — 2 transactions totaling $0
View all SEC Filings for Allarity Therapeutics, Inc. (ALLR).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 28, 2026 | Jensen Thomas | CEO | A | Common Stock | 200000 | $0.00 | 596,734.0000 | 15,811,886 | 50.41% | 1.26% |
| Jan. 7, 2026 | Hoeiland Jesper | Director | A | Common Stock | 25000 | $0.00 | 25,000.0000 | 15,811,886 | 9999.99% | 0.16% |
| Jan. 28, 2026 | McLaughlin Gerald W. | Director | A | Common Stock | 45000 | $0.00 | 70,000.0000 | 15,811,886 | 180.00% | 0.28% |
| Jan. 28, 2026 | Ervin Jeffrey S | CFO | A | Common Stock | 150000 | $0.00 | 150,000.0000 | 15,811,886 | 9999.99% | 0.95% |
| Jan. 28, 2026 | Graff Jeremy R. | See Remarks | A | Common Stock | 133333 | $0.00 | 381,644.0000 | 15,811,886 | 53.70% | 0.84% |
| Jan. 7, 2026 | Graff Jeremy R. | See Remarks | A | Common Stock | 133333 | $0.00 | 381,644.0000 | 15,811,886 | 53.70% | 0.84% |
| Sept. 30, 2025 | Graff Jeremy R. | See Remarks | F | Common Stock | 14613 | $1.58 | 24,881.0000 | 17,014,737 | 37.00% | 0.09% |
| Sept. 30, 2025 | Graff Jeremy R. | See Remarks | M | Restricted Stock Units | 39494 | $0.00 | 223,430.0000 | 17,014,737 | 15.02% | 0.23% |
| Sept. 30, 2025 | Graff Jeremy R. | See Remarks | M | Common Stock | 39494 | $0.00 | 39,494.0000 | 17,014,737 | 9999.99% | 0.23% |
| Jan. 22, 2025 | McLaughlin Gerald W. | Director | A | Stock Options | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2025 | Epshinsky Alexander | CFO | A | Common Stock | 29496 | $0.00 | 85,051.0000 | 0 | 53.09% | 0.00% |
| Jan. 22, 2025 | Jensen Thomas | CEO | A | Common Stock | 396734 | $0.00 | 396,734.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2025 | Vazzano Joseph Walter | Director | A | Stock Options | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2025 | Benjamin Laura | Director | A | Stock Options | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2025 | Graff Jeremy R. | CDO | A | Common Stock | 144441 | $0.00 | 262,924.0000 | 0 | 121.91% | 0.00% |
| Jan. 22, 2025 | McLaughlin Gerald W. | Director | A | Stock Options | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2025 | Vazzano Joseph Walter | Director | A | Stock Options | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2025 | Benjamin Laura | Director | A | Stock Options | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2024 | Graff Jeremy R. | See Remarks | A | Common Stock | 118483 | $2.11 | 118,483.0000 | 0 | 9999.99% | 0.00% |